News
Archive
Novadip Biosciences SA announces positive results from Phase 1/2 clinical trial in patients with severe bone non-union of the lower limb following trauma
Ventyx Biosciences announces dosing of the first patient in the Phase 2 SERENITY trial of VTX958 for the treatment of moderate to severe plaque psoriasis
Resolve Therapeutics completes enrollment of Phase II Long Covid clinical trial
Novadip Biosciences raises additional EUR 40 Million bringing total company funding to EUR 88 Million
Phase Four unveils game changing engine for LEO Constellations
Ventyx Biosciences announces positive topline Phase I data for its selective allosteric TYK2 inhibitor VTX958
Back To News
November 1, 2017
Big Data: Drilling for value
Data in the 21st Century is like Oil in the 18th Century: an immensely, untapped valuable asset, according to Wired, amongst others. Like oil, for those who see data’s fundamental value and learn to extract and use it there will be huge rewards. And, indeed for some time now, the lure of big data has been a … Continue reading “Big Data: Drilling for value”
The post Big Data: Drilling for value appeared first on Fuzzy Logix.